Back to Results
First PageMeta Content
Thiazolidinediones / Sulfonylureas / Amides / Dipeptidyl peptidase-4 inhibitors / Pioglitazone / Metformin / Sitagliptin / Gliclazide / Glibenclamide / Chemistry / Organic chemistry / Eli Lilly and Company


Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch January 1, 2012 Bulletin #131 ISSN 1923-077X
Add to Reading List

Document Date: 2014-06-26 15:57:49


Open Document

File Size: 40,47 KB

Share Result on Facebook

Company

Mylan / 077X SASKATCHEWAN FORMULARY BULLETIN / /

Event

FDA Phase / /

IndustryTerm

diabetes treatment / /

MedicalCondition

positive infections / stent thrombosis / Fungal meningitis / combination diabetes / diabetes / refractory partial-onset seizures / Gram-positive infections / i.e. leukemia / infectious disease / fungal infections / /

MedicalTreatment

oral therapy / /

Organization

Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch / Ministry of Health / /

/

Position

CO Fluconazole-COB / cardiologist / infectious disease specialist / CO Pioglitazone-COB / neurologist / /

Product

pioglitazone / Effient tablet / Toctino capsule / 100mg / Janumet / 50mg / 50mg/1000mg / Diflucan / linezolid / 5mg / Actonel / 50mg/850mg / ketoconazole / glyburide / 2Product DIN Januvia / Mycamine / 10mg / Januvia / Actos / Onglyza tablet / fluconazole / 50mg/500mg / Listing / /

ProvinceOrState

Saskatchewan / /

Technology

Dom / /

SocialTag